Curcumin as a Novel Treatment to Improve Cognitive Dysfunction in Schizophrenia

The requested reference [375b090a9fa2f4daf354f49bd11c1a3d84ee315f] no longer exists in our database. It has been replaced by the current reference: [f38741028806983282ed2284238822986cd3d57d]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The investigators propose to test whether curcumin nanoparticles will improve behavioral measures and biomarkers of cognition and neuroplasticity in patients with schizophrenia who are already receiving a stable dose of antipsychotic.
Epistemonikos ID: 130d47007ffa0110b7c4bc0f5d56be07b9637717
First added on: May 11, 2024